Medical Laboratory Scientist Interview Questions 2026

Medical laboratory scientist interviews assess your technical depth across multiple disciplines, your quality-control mindset, and your ability to handle critical or unexpected results. Whether you're interviewing for a hospital core lab, reference lab, or specialty position, these are the questions you'll encounter in 2026.

Hematology and CBC Interpretation

1. "How do you verify a platelet count that appears critically low on the instrument?" Manual peripheral smear review to rule out platelet clumping (EDTA-induced pseudothrombocytopenia). If clumping is present, request a citrate or heparin tube for recount. Document findings and call the provider with the slide review result. This is a fundamental quality-control question.
2. "Describe a left shift on a CBC differential. When is it clinically significant?" Increased bands and immature granulocytes (metamyelocytes, myelocytes) — left shift. Clinically significant in context of infection, sepsis, or bone marrow stress. Distinguish from leukoerythrooblastic reaction (also RBCs in circulation). Shows you read results in clinical context.
3. "What are the ICSH criteria for manual differential review, and when do you trigger them?" Instrument flags (blasts, atypical lymphs, immature granulocytes), critical values, abnormal WBC/PLT counts, first-time samples. The question tests whether you have a systematic review trigger protocol, not just personal judgment.

Clinical Chemistry

4. "Walk me through how you investigate a result that fails a delta check." Compare to previous result within the delta check timeframe. Consider: was sample drawn correctly (pre-analytical error — hemolysis, lipemia, wrong tube)? Is there a clinical reason for the change? Re-run if needed, verify patient ID, contact floor if pre-analytical error suspected. Document all steps.
5. "How do you detect lipemic, icteric, or hemolyzed samples, and what's your interference protocol?" Automated serum indices (HIL) on modern analyzers. Know which analytes are most affected: hemolysis affects K+, LD, AST; lipemia affects most photometric assays; icterus affects bilirubin assays and some electrolytes. Know your analyzer's specific interference thresholds.
6. "A sodium result comes back at 168 mEq/L on a patient with no clinical correlation. What do you do?" Hyperlipidemia or hyperproteinemia causing pseudohypernatremia (if using indirect ISE). Run with direct ISE or check HIL indices. If genuine, it's a critical value — call the provider. Delta check against previous result.

Microbiology

7. "How do you evaluate a sputum specimen for quality before processing for culture?" Gram stain: >25 PMNs per low-power field (lpf) and <10 squamous epithelial cells (SEC) per lpf indicates good quality. Reject if predominantly squamous cells — salivary contamination. This is a basic but frequently asked quality assessment question.
8. "Describe your process for working up a Gram-positive cocci in clusters from a blood culture." Preliminary report — Gram stain result to provider immediately. Sub to blood agar and CHROM agar, coagulase test (or MALDI-TOF). Distinguish S. aureus from CoNS. Sensitivity testing (MRSA screen, MIC). Timely communication of preliminary vs. final results.
9. "What's your approach to an unusual or unexpected susceptibility pattern — for example, a Klebsiella that appears carbapenem-resistant?" Repeat testing, check for ESBL, KPC, NDM via confirmatory phenotypic or genotypic methods. Notify infection control and infectious disease immediately. Flag for multi-drug resistant organism (MDRO) protocol. This tests MDRO surveillance awareness.

Quality Control and Regulatory

10. "A QC sample is out of range on your chemistry analyzer. What do you do before reporting patient results?" Don't report patient results. Troubleshoot: check reagent expiration/lot, verify calibration, run repeat QC, check for instrument flags or maintenance needs. If QC passes after troubleshooting, document and report. If not, call the supervisor and take the analyzer offline for patient testing.
11. "What are the Westgard rules, and which do you apply in your lab's QC protocol?" At minimum, describe 1₂s (warning), 1₃s (rejection), 2₂s, R₄s, and 10x rules. Show you understand that the rule set balances error detection with false rejection rates, and that your lab applies them based on CLIA requirements and risk assessment.
12. "How do you handle a critical value notification, and what's your documentation standard?" Per CAP and CLIA: call directly to a licensed caregiver, read back the value, document the time, who you spoke with, their readback confirmation, and medical record number. Never leave a message for a critical value. This is a compliance question as much as a clinical one.

Transfusion Medicine / Blood Bank (if applicable)

13. "Describe the steps in a Type and Screen vs. Type and Crossmatch." T&S: ABO/Rh determination + antibody screen. Crossmatch: actual compatibility test of patient serum against donor red cells. Electronic crossmatch (2 concordant Type and Screen results, negative antibody screen) is valid at most institutions. Physical crossmatch required when antibody screen is positive or history of clinically significant antibodies.
14. "A patient has a panreactive antibody screen. How do you proceed?" Perform autocontrol, check for warm autoantibody vs. alloantibody. Contact blood bank medical director or reference lab. For transfusion-dependent patients, extended phenotype and least-incompatible blood may be necessary.

Communication and Critical Thinking

15. "How do you prioritize your workload during a STAT surge in a busy overnight shift?" Triage by clinical urgency (sepsis workup > routine chemistry), communicate expected turnaround time to nursing/providers if delays, notify supervisor if staffing is inadequate to meet TAT requirements. Shows operational awareness, not just bench work.
16. "Describe a time you caught an error that could have harmed a patient." Have a specific example ready. Structure it: what the error was, how you identified it, what you did to prevent harm, and what process change resulted. Labs that don't encourage error reporting have worse quality outcomes — interviewers want MLS candidates who surface problems.

Questions to Ask the Interviewer

• What analyzer platforms does the core lab run for chemistry and hematology?
• What's the TAT target for STAT troponin and CBC results?
• Is there a clinical laboratory scientist rotation through blood bank, micro, and chemistry, or are staff specialized?
• What CE and certification support does the lab provide (ASCP, AMT)?

Related: Nurse Interview Questions, Pharmacist Interview Questions, Healthcare Job Description Guide. Browse MLS positions at avahealth.co.